Joglekar T - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Deep PIM kinase substrate profiling reveals new rational cotherapeutic strategies for acute myeloid leukemia.

Joglekar T, Chin A, Voskanian-Kordi A, Baek S, Raja A, Rege A, Huang W, Kane M, Laiho M, Webb TR, Fan X, Rubenstein M, Bieberich CJ, Li X. Joglekar T, et al. Blood Adv. 2024 Aug 13;8(15):3880-3892. doi: 10.1182/bloodadvances.2022008144. Blood Adv. 2024. PMID: 38739710 Free PMC article.

ONECUT2 is a novel target for treatment of castration-resistant prostate cancer.

Joglekar T, Lin J, Shibata M. Joglekar T, et al. Expert Opin Ther Targets. 2020 Feb;24(2):89-90. doi: 10.1080/14728222.2020.1723080. Epub 2020 Feb 3. Expert Opin Ther Targets. 2020. PMID: 31983247 Free PMC article. No abstract available.

Identification of infusion strategy for achieving repeatable nanoparticle distribution and quantification of thermal dosage using micro-CT Hounsfield unit in magnetic nanoparticle hyperthermia.

LeBrun A, Joglekar T, Bieberich C, Ma R, Zhu L. LeBrun A, et al. Among authors: joglekar t. Int J Hyperthermia. 2016;32(2):132-43. doi: 10.3109/02656736.2015.1119316. Epub 2016 Jan 12. Int J Hyperthermia. 2016. PMID: 26758242 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters